We are live on
!
Find out more
JGC
J. Goldman & Co Portfolio holdings
AUM
$3.44B
1-Year Est. Return
33.8%
This Fund
S&P 500
This Quarter
Est. Return
+2.45%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$1.51B
AUM Growth
-$260M
(-15%)
Cap. Flow
-$299M
Cap. Flow
% of AUM
-19.83%
Top 10 Holdings %
Top 10 Hldgs %
22.69%
Holding
457
New
159
Increased
49
Reduced
66
Closed
173
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bath & Body Works
BBWI
|
+$34.6M |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$30.5M |
| 3 |
NXP Semiconductors
NXPI
|
+$24.9M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$22.3M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$21.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$36M |
| 2 |
LNKD
LinkedIn Corporation
LNKD
|
+$20.5M |
| 3 |
Salesforce
CRM
|
+$19.8M |
| 4 |
Canadian Pacific Kansas City
CP
|
+$16.3M |
| 5 |
JWN
Nordstrom
JWN
|
+$15.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 8.96% |
| 2 | Industrials | 7.86% |
| 3 | Technology | 6.74% |
| 4 | Communication Services | 5.76% |
| 5 | Healthcare | 3.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGYP
226
PUT
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $898K | 0.06% |
+147,500
| New | +$771K |
|
227
Golar LNG
GLNG
$4.95B
| $872K | 0.06% |
38,000
-184,737
| -83% | -$4.3M |
|
228
Amazon
AMZN
$2.48T
| $862K | 0.06% |
23,000
-32,200
| -58% | -$1.26M |
|
|
NVTR
229
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $835K | 0.06% |
165,910
| – | – |
|
230
Universal Technical Institute
UTI
$2.15B
| $832K | 0.06% |
285,873
-139,827
| -33% | -$323K |
|
231
Prudential Financial
PRU
$43B
| $796K | 0.05% |
+7,650
| New | +$725K |
|
|
CTRA
232
DELISTED
Coterra Energy
CTRA
| $790K | 0.05% |
+33,800
| New | +$760K |
|
233
PTC Therapeutics
PTCT
$6.25B
| $763K | 0.05% |
+69,950
| New | +$734K |
|
234
Macy's
M
$6.62B
| $752K | 0.05% |
+21,000
| New | +$817K |
|
235
VanEck Oil Services ETF
OIH
$1.99B
| $724K | 0.05% |
+1,085
| New | +$675K |
|
|
HRC
236
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $716K | 0.05% |
+12,750
| New | +$723K |
|
237
TripAdvisor
TRIP
$1.74B
| $709K | 0.05% |
+15,300
| New | +$841K |
|
238
Cigna
CI
$79.6B
| $707K | 0.05% |
+5,300
| New | +$694K |
|
239
Thermo Fisher Scientific
TMO
$214B
| $706K | 0.05% |
+5,000
| New | +$737K |
|
240
McKesson
MCK
$104B
| $702K | 0.05% |
+5,000
| New | +$736K |
|
241
ConocoPhillips
COP
$139B
| $692K | 0.05% |
+13,800
| New | +$636K |
|
242
Axalta
AXTA
$7.58B
| $680K | 0.05% |
25,000
+23,800
| +1,983% | +$626K |
|
243
Jack in the Box
JACK
$308M
| $659K | 0.04% |
5,900
-67,385
| -92% | -$6.88M |
|
244
eBay
EBAY
$52.1B
| $632K | 0.04% |
+21,300
| New | +$629K |
|
245
Zedge
ZDGE
$38.4M
| $629K | 0.04% |
200,904
| – | – |
|
246
Chord Energy
CHRD
$7.25B
| $606K | 0.04% |
+40,000
| New | +$518K |
|
247
SPDR Gold Trust
GLD
$131B
| $581K | 0.04% |
+5,300
| New | +$615K |
|
|
CBAY
248
DELISTED
Cymabay Therapeutics
CBAY
| $571K | 0.04% |
+330,207
| New | +$583K |
|
|
ALXN
249
DELISTED
Alexion Pharmaceuticals
ALXN
| $563K | 0.04% |
+4,600
| New | +$563K |
|
250
State Street SPDR S&P Regional Banking ETF
KRE
$4.55B
| $556K | 0.04% |
+10,000
| New | +$490K |
|
Similar funds
CIA
PWP
RBA
CCM
PCM
LNC
DAM
OTPPB
J. Goldman & Co's Q4 2016 Portfolio in Review
As of Q4 2016, J. Goldman & Co held 457 positions worth $1.51B, down 15% from $1.77B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
J. Goldman & Co withdrew a net $299M in Q4 2016, closing 173 positions and reducing 66 holdings. Its most notable exit was PepsiCo, an estimated $36M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 9% of assets, up from 8.1% a quarter earlier, followed by Industrials and Technology.
Against the trend, J. Goldman & Co opened a new position in Bath & Body Works worth $32.3M.
- J. Goldman & Co's largest Q4 2016 buy was Bath & Body Works: 607,676 shares worth $32.3M.
- J. Goldman & Co added most to iShares Core S&P 500 ETF in Q4 2016, an estimated $21.9M increase.
- J. Goldman & Co's biggest Q4 2016 reduction was TrueCar, cutting an estimated $14.6M.
- J. Goldman & Co fully exited PepsiCo in Q4 2016, selling an estimated $36M.
- J. Goldman & Co's ten largest holdings make up 23% of its $1.51B portfolio in Q4 2016.
- J. Goldman & Co opened 159 new positions and closed 173 in Q4 2016.
- J. Goldman & Co's portfolio value fell 15% quarter-over-quarter to $1.51B.
Based on J. Goldman & Co's 13F filing for Q4 2016, filed 13 Feb 2017.